Trial intelligence / Profile preview

Elobixibat for constipation in end stage kidney disease patients undergoing hemodialysis

TCTR20230317007Phase 3Completed

Sponsor
Phramongkutklao Hospital
Start
Sep 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of elobixibat in constipation, sponsored by Phramongkutklao Hospital. Started Sep 2022; status: completed.

02

Drugs

elobixibat
03

Conditions

constipation

Beyond the preview

Go deeper on TCTR20230317007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230317007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call